Progress toward improved Wilson's disease drug

(Cold Spring Harbor Laboratory) Researchers at CSHL, working in collaboration with DepYmed Inc., a CSHL spinout company, today report that they have conducted promising preclinical experiments on a compound that could be used to treat Wilson's disease and possibly other disorders -- including certain types of cancer -- in which levels of copper in the body are elevated, causing or contributing to pathology.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news